Oliver wyman completes acquisition of huron's life sciences strategy consulting practice

New york--(business wire)--oliver wyman, a global management consulting firm and a business of marsh mclennan (nyse: mmc), today completed the acquisition of huron's life sciences strategy consulting practice. terms of the acquisition were not disclosed. “through this combination, we will continue our relentless pursuit of a better way in healthcare, partnering with pharmaceutical, biotechnology, and medical device companies. our new colleagues bring the expertise needed to help life sciences c
MMC Ratings Summary
MMC Quant Ranking